|
Market Closed -
OTC Markets
22:12:15 28/07/2025 +03
|
5-day change | 1st Jan Change | ||
| 30.92 USD | +24.45% |
|
-.--% | - |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,175.59 | +17.46% | 32 | |||||||
| 14,433.33 | +29.33% | 12 | |||||||
| 1,197.45 | -0.54% | 30 | |||||||
| 1,509.08 | +7.81% | 36 | |||||||
| 257.83 | -0.83% | 6 | |||||||
| 13,214.57 | +5.89% | 7 | |||||||
| 2,497.73 | +4.95% | 11 | |||||||
| - | 2,508.33 | +2.72% | 12 | ||||||
| - | - | - | - | - | |||||
| 3,796.46 | +7.01% | 13 | |||||||
| 172.67 | +9.97% | 3 | |||||||
| 15.11 | +57.72% | 4 | |||||||
| - | - | - | - | - | |||||
| - | - | 133.12 | +2.33% | 2 | |||||
| - | 154.68 | +19.08% | 4 | ||||||
| - | - | 14.6 | +10.44% | 1 | |||||
| - | 2,765 | -2.5% | 2 | ||||||
| Average | 2,989.7 | +11.39% | 12 | ||||||
| Weighted average by Cap. | 5,159.33 | +15.16% | 19 |
- Stock Market
- Stocks
- RICHTER Stock
- GEDSF Stock
- Sector Gedeon Richter
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















